| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 04/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/27/21 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 04/16/21 | 8-K | Current report filing |
|
4 | |
| 04/16/21 | 3 | Initial statement of beneficial ownership of securities |
|
2 | |
| 04/16/21 | 3 | Initial statement of beneficial ownership of securities |
|
1 | |
| 04/14/21 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
39 |
| 03/03/21 | EFFECT | Notice of Effectiveness |
|
1 | |
| 03/03/21 | 424B3 | Prospectus filed pursuant to Rule 424(b)(3) |
|
136 | |
| 02/26/21 | POS AM | Post-effective amendment to a registration statement that is not immediately effective upon filing |
|
|
147 |
Lexaria Bioscience Corp.
Lexaria Bioscience Corp.